SEC Form 4 · accession 0001179110-15-009416
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Hagen
Officer — SVP Manufacturing & Pharmaceut
Period of report
Jun 8, 2015
Accepted (ET)
Jun 9, 2015 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2015 | M | 5,000 | $10.43 | A | 33,700 | D | |
| Common Stock | Jun 8, 2015 | S | 5,000 | $19.99 | D | 28,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $10.43 | Jun 8, 2015 | M | 5,000 | A | — | Feb 4, 2024 | Common Stock | 5,000 | 20,000 | D |
Explanation of responses
- F1Grant vests 25% per year on each of the first 4 anniversaries of the date of grant (February 4, 2014). The 5,000 shares being exercised represent a portion of the vested grant.